WuXi AppTec, a drugmaker in China that manufactures multiple chemotherapies for U.S. patients, is facing scrutiny from lawmakers concerned about security threats, The New York Times reported April 15.
WuXi AppTec, a drugmaker in China that manufactures multiple chemotherapies for U.S. patients, is facing scrutiny from lawmakers concerned about security threats, The New York Times reported April 15.
Copyright © 2024 | WordPress Theme by MH Themes
